2nd Quarter - Report

ALERE INC. for ALERE INC.

Firm
Client
Income
—
Expenses
$157,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA regulation of clinical diagnostic laboratory tests. FDA regulation of prescription drugs. The Generating Antibiotics Incentives Now Act (H.R. 2182)

LobbyistCovered position, as disclosed
SETH M RADUS —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 2182 (112th)

Medical/Disease Research/Clinical Labs MED

Development of new and innovative clinical diagnostic laboratory tests.

LobbyistCovered position, as disclosed
SETH M RADUS —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare payment for clinical diagnostic laboratory tests. The Patient Protection and Affordable Care Act (P.L. 111-148): Implementation of provisions on Accountable Care Organizations, health risk assessments in the annual wellness benefit, as well as the "prevention fund".

LobbyistCovered position, as disclosed
SETH M RADUS —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.